Is Povidone (PVP, K30) safe for babies and kids?
Moderate risk for kidsInfants are more vulnerable to Povidone (PVP, K30) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What is povidone (pvp, k30)?
Also known as: Polyvinylpyrrolidone, polivinilpirrolidona, Poliwinylopirolidon, povidona.
- CAS number
- 9003-39-8
- SMILES
- *-CC(-*)N1CCCC1=O |$star_e;;;star_e;;;;;;$,lp:4:1,9:2,Sg:n:7,6,5,4,8,9,2,1::ht|
Risk for babies
Moderate riskInfants are more vulnerable to Povidone (PVP, K30) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of Povidone (PVP, K30), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
4 regulatory and scientific bodies have classified Povidone (PVP, K30). The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| US FDA / EFSA (Povidone — polyvinylpyrrolidone; PVP — FDA-approved pharmaceutical excipient (inactive ingredient database; oral, topical, parenteral routes); EFSA ADI 50 mg/kg bw/day for povidone (E1201); no carcinogenicity classification by IARC, NTP, US EPA, or EFSA for the polymer; residual monomer N-vinylpyrrolidone (NVP) is a process impurity controlled by ICH Q3B limits — NVP itself classified as possibly genotoxic; tissue accumulation with high-dose parenteral administration documented historically (thesaurismosis); povidone-iodine complex (Betadine) is a separate antimicrobial compound with different safety profile) | 2019 | no carcinogenicity classification for PVP polymer; FDA-approved excipient; EFSA ADI 50 mg/kg bw/day; residual NVP monomer genotoxicity concern controlled by pharmacopeial limits; tissue accumulation with parenteral administration; not classified by IARC, NTP, or EPA for carcinogenicity | |
| EPA CTX / IARC | — | Group 3 - Not classifiable as to its carcinogenicity to humans | |
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 4 positive / 1 negative reports) | |
| EPA CTX / Genetox | — | Genotoxicity: positive (Ames: positive, 4 positive / 1 negative reports) |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter povidone (pvp, k30)
- Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
- Occupational Environments — Factories, Warehouses, Transportation vehicles
- Consumer Products — dietary supplements, fortified foods, energy drinks
Safer alternatives
Lower-risk approaches that achieve a similar outcome to Povidone (PVP, K30):
-
Inherently flame-resistant materials (wool, modacrylic, Nomex)
Trade-offs: Higher material cost. Limited color/texture options.Relative cost: 1.2-2×
-
Barrier fabric technology
Trade-offs: Adds manufacturing step and costRelative cost: 1.2-2×
Frequently asked questions
Is povidone (pvp, k30) safe for kids?
Infants are more vulnerable to Povidone (PVP, K30) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What products contain povidone (pvp, k30)?
Povidone (PVP, K30) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments); dietary supplements (Consumer products).
What should I do if my child is exposed to povidone (pvp, k30)?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
Why do regulators disagree about povidone (pvp, k30)?
Povidone (PVP, K30) has been classified by 4 agencies including US FDA / EFSA (Povidone — polyvinylpyrrolidone; PVP — FDA-approved pharmaceutical excipient (inactive ingredient database; oral, topical, parenteral routes); EFSA ADI 50 mg/kg bw/day for povidone (E1201); no carcinogenicity classification by IARC, NTP, US EPA, or EFSA for the polymer; residual monomer N-vinylpyrrolidone (NVP) is a process impurity controlled by ICH Q3B limits — NVP itself classified as possibly genotoxic; tissue accumulation with high-dose parenteral administration documented historically (thesaurismosis); povidone-iodine complex (Betadine) is a separate antimicrobial compound with different safety profile), EPA CTX / IARC, EPA CTX / Genetox, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.
See Povidone (PVP, K30) in the baby app
Look up products containing povidone (pvp, k30), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (1)
- FDA Inactive Ingredient Database Povidone Oral Topical Ophthalmic; EFSA E1201 ADI 50 mg/kg bw/day; NVP Residual Monomer Genotoxicity ICH Q3B Limit 10 ppm; Historical Thesaurismosis Parenteral Accumulation; Wine Fining Agent; No IARC NTP EPA Carcinogenicity Classification (2019) — regulatory
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →